IV Flush Syringe Market Size [2022] | to extend USD 428.0 million by 2028, exhibiting a CAGR of 5.7%

Pune, India, Feb. 22, 2022 (GLOBE NEWSWIRE) — The global IV flush syringe market size is expected to grow from USD 290.9 million in 2021 to USD 428.0 million by 2028, exhibiting a CAGR of 5.7% during the forecast period. Robust demand for the product from the healthcare sector and rapid development and expansion from novel products is expected to boost market progress. Fortune Business Insights™ presents this information in its report titled “IV Flush Syringe Market, 2021-2028.”  

Industry Development

• April 2021: Nipro Corporation introduced CURACASE, a Hypodermic needle used for Hard-Plastic Unit Packaging. The needles can strengthen the supply and manufacturing of injection systems.

Request a Sample: https://www.fortunebusinessinsights.com/enquiry/sample/iv-flush-syringe-market-106368

Report Scope & Segmentation

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/iv-flush-syringe-market-106368

Drivers and Restraints

Favorable Guidelines and Rising Awareness to Bolster Market Development

Rising chronic disorders is expected to boost the demand for IV flush syringe. As per the data provided by the Healthcare Cost & Utilization Project, in the U.S., arthritis, cardiac diseases, COPD, and diabetes are factors facilitating in-patient hospital stays in the U.S. Rising medical expenditures and demand for high-quality medical equipment are expected to foster the demand for the product.

Furthermore, stringent government guidelines for the adoption of IV flush syringe is expected to drive the IV flush syringe market growth.

Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/iv-flush-syringe-market-106368

Regional Insights

• North America is expected to dominate the IV flush syringe market share because of the rising product adoption and in-patient admissions. The market in North America stood at USD 122.5 million in 2020 and is expected to grow positively in the upcoming years. Furthermore, rising surgical procedures are expected to bolster market development.
• In Europe, rapid healthcare infrastructure development is expected to boost IV flush syringe adoption. Furthermore, the rapid development of healthcare facilities in several Asian countries is expected to propel market development. In addition, rising technological advancements and surgical procedures are expected to boost industry growth.
• In Asia Pacific, rising medical facilities and increasing surgical procedures are expected to boost adoption. In addition, rising in-hospital stays may foster industry development.

Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/iv-flush-syringe-market-106368

Competitive Landscape

Prominent companies operating in the IV Flush Syringe Market invest heavily in manufacturing expansion to increase manufacturing facility efficiency and boost market position. For example, Medefil, Inc. undertook manufacturing expansion to improve manufacturing facility efficiency in June 2019. This strategy can improve the production of flushes and injectable products. This strategy may enable the company to improve product quality, boost production and achieve a remarkable market position. Additionally, companies adopt research and development, mergers, partnerships, novel product launches, and acquisition strategies to boost their market position.

List of Key Players Profiled in the IV Flush Syringe Market Report

• BD (Becton, Dickinson and Company) (U.S.)
• B. Braun Melsungen AG (Germany)
• Cardinal Health (U.S.)
• Nipro Corporation (Japan)
• Medline Industries, LP (U.S.)
• Medefil, Inc. (U.S.)
• Polymedicure (India)
• Aquabiliti (U.S.)
• SteriCare Solutions (U.S.)

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

U.S. :+1 424 253 0390

U.K. : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]